169 related articles for article (PubMed ID: 20078863)
1. The transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR.
Guyot R; Vincent S; Bertin J; Samarut J; Ravel-Chapuis P
BMC Mol Biol; 2010 Jan; 11():3. PubMed ID: 20078863
[TBL] [Abstract][Full Text] [Related]
2. Aurora-C interacts with and phosphorylates the transforming acidic coiled-coil 1 protein.
Gabillard JC; Ulisse S; Baldini E; Sorrenti S; Cremet JY; Coccaro C; Prigent C; D'Armiento M; Arlot-Bonnemains Y
Biochem Biophys Res Commun; 2011 May; 408(4):647-53. PubMed ID: 21531210
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the transforming acidic coiled-coil 1 (TACC1) protein with ch-TOG and GAS41/NuBI1 suggests multiple TACC1-containing protein complexes in human cells.
Lauffart B; Howell SJ; Tasch JE; Cowell JK; Still IH
Biochem J; 2002 Apr; 363(Pt 1):195-200. PubMed ID: 11903063
[TBL] [Abstract][Full Text] [Related]
4. TACC1-chTOG-Aurora A protein complex in breast cancer.
Conte N; Delaval B; Ginestier C; Ferrand A; Isnardon D; Larroque C; Prigent C; Séraphin B; Jacquemier J; Birnbaum D
Oncogene; 2003 Nov; 22(50):8102-16. PubMed ID: 14603251
[TBL] [Abstract][Full Text] [Related]
5. AINT/ERIC/TACC: an expanding family of proteins with C-terminal coiled coil domains.
Lappin TR; Mullan RN; Stewart JP; Morgan NA; Thompson A; Maxwell AP
Leuk Lymphoma; 2002 Jul; 43(7):1455-9. PubMed ID: 12389629
[TBL] [Abstract][Full Text] [Related]
6. A novel cytoplasmic adaptor for retinoic acid receptor (RAR) and thyroid receptor functions as a Derepressor of RAR in the absence of retinoic acid.
Park UH; Kim EJ; Um SJ
J Biol Chem; 2010 Oct; 285(44):34269-78. PubMed ID: 20736163
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
8. Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties.
Lee S; Privalsky ML
Mol Endocrinol; 2005 Apr; 19(4):863-78. PubMed ID: 15650024
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators.
Conte N; Charafe-Jauffret E; Delaval B; Adélaïde J; Ginestier C; Geneix J; Isnardon D; Jacquemier J; Birnbaum D
Oncogene; 2002 Aug; 21(36):5619-30. PubMed ID: 12165861
[TBL] [Abstract][Full Text] [Related]
10. RIF-1, a novel nuclear receptor corepressor that associates with the nuclear matrix.
Li HJ; Haque ZK; Chen A; Mendelsohn M
J Cell Biochem; 2007 Nov; 102(4):1021-35. PubMed ID: 17455211
[TBL] [Abstract][Full Text] [Related]
11. Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines.
Xiang J; Qiu W; Wang X; Zhou F; Wang Z; Liu S; Yue L
Oncol Rep; 2013 Apr; 29(4):1517-23. PubMed ID: 23354013
[TBL] [Abstract][Full Text] [Related]
12. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators).
Le Douarin B; vom Baur E; Zechel C; Heery D; Heine M; Vivat V; Gronemeyer H; Losson R; Chambon P
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):569-78. PubMed ID: 8735280
[TBL] [Abstract][Full Text] [Related]
13. Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.
Watashi K; Hijikata M; Tagawa A; Doi T; Marusawa H; Shimotohno K
Mol Cell Biol; 2003 Nov; 23(21):7498-509. PubMed ID: 14559998
[TBL] [Abstract][Full Text] [Related]
14. Synthetic retinoids dissociate coactivator binding from corepressor release.
Zechel C
J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
[TBL] [Abstract][Full Text] [Related]
15. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.
Cully M; Shiu J; Piekorz RP; Muller WJ; Done SJ; Mak TW
Cancer Res; 2005 Nov; 65(22):10363-70. PubMed ID: 16288026
[TBL] [Abstract][Full Text] [Related]
16. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R
EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876
[TBL] [Abstract][Full Text] [Related]
17. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
Loinder K; Söderström M
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
[TBL] [Abstract][Full Text] [Related]
18. Altered splicing pattern of TACC1 mRNA in gastric cancer.
Line A; Slucka Z; Stengrevics A; Li G; Rees RC
Cancer Genet Cytogenet; 2002 Nov; 139(1):78-83. PubMed ID: 12547166
[TBL] [Abstract][Full Text] [Related]
19. Temporal and spatial expression of TACC1 in the mouse and human.
Lauffart B; Dimatteo A; Vaughan MM; Cincotta MA; Black JD; Still IH
Dev Dyn; 2006 Jun; 235(6):1638-47. PubMed ID: 16496324
[TBL] [Abstract][Full Text] [Related]
20. Xenopus TACC1 is a microtubule plus-end tracking protein that can regulate microtubule dynamics during embryonic development.
Lucaj CM; Evans MF; Nwagbara BU; Ebbert PT; Baker CC; Volk JG; Francl AF; Ruvolo SP; Lowery LA
Cytoskeleton (Hoboken); 2015 May; 72(5):225-34. PubMed ID: 26012630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
